Abstract:Alzheimer disease (AD) is a progressive and deleterious neurodegenerative disorder that affects mostly the elderly population. At the moment, no effective treatments are available in the market, making the whole situation a compelling challenge for societies worldwide. Recently, novel mechanisms have been proposed to explain the etiology of this disease leading to the new concept that AD is a multifactor pathology. Among others, the function of mitochondria has been considered as one of the intracellular processes severely compromised in AD since the early stages and likely represents a common feature of many neurodegenerative diseases. Many mitochondrial parameters decline already during the aging, reaching an extensive functional failure concomitant with the onset of neurodegenerative conditions, although the exact timeline of these events is still unclear. Thereby, it is not surprising that mitochondria have been already considered as therapeutic targets in neurodegenerative diseases including AD. Together with an overview of the role of mitochondrial dysfunction, this review examines the pros and cons of the tested therapeutic approaches targeting mitochondria in the context of AD. Since mitochondrial therapies in AD have shown different degrees of progress, it is imperative to perform a detailed analysis of the significance of mitochondrial deterioration in AD and of a pharmacological treatment at this level. This step would be very important for the field, as an effective drug treatment in AD is still missing and new therapeutic concepts are urgently needed.

Mitochondrial dysfunction as a therapeutic strategy for neurodegenerative diseases: Current Insights and Future Directions

Therapeutic and tampering approaches for mitochondrial associated diseases

Mitochondrial Dysfunction in Microglia: a Novel Perspective for Pathogenesis of Alzheimer’s Disease

Mitochondrial dysfunction: mechanisms and advances in therapy

Modulation of Mitochondrial Function as a Therapeutic Strategy for Neurodegenerative Diseases

Mitochondrial Dysfunction and Biogenesis in Neurodegenerative diseases: Pathogenesis and Treatment

Mitochondrial dysfunction in neurological disorders: Exploring mitochondrial transplantation

Molecular mechanisms of mitophagy and its roles in neurodegenerative diseases

Mitochondrial dysfunction in Alzheimer's disease: Role in pathogenesis and novel therapeutic opportunities

Mitochondrial dysfunction in the development and progression of neurodegenerative diseases

Mitochondrial Dysfunction in Neurodegenerative Diseases and the Potential Countermeasure

Role of Mitochondrial Dysfunctions in Neurodegenerative Disorders: Advances in Mitochondrial Biology

Mitochondrial Dynamics: A Key Role in Neurodegeneration and a Potential Target for Neurodegenerative Disease

Advances in novel anti-neurodegenerative diseases drugs targeting mitochondria

Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances

Mitochondrial dysfunction in neurodegenerative disorders: Potential therapeutic application of mitochondrial transfer to central nervous system-residing cells

Mitochondrial Dysfunction in Parkinson's Disease: From Mechanistic Insights to Therapy

Mitochondria as Potential Targets in Alzheimer Disease Therapy: An Update

Role of Mitophagy in neurodegenerative Diseases and potential tagarts for Therapy

Mitochondrial Dynamics in Brain Cells During Normal and Pathological Aging

Progress in mitochondrial and omics studies in Alzheimer's disease research: from molecular mechanisms to therapeutic interventions